Vital signs: Cervical cancer incidence, mortality, and screening — United States, 2007–2012

Morbidity and Mortality Weekly Report

Volumn 63, Issue 44, 2014, Pages 1004-1009

  Benard, Vicki B ^a   Thomas, Cheryll C ^a   King, Jessica ^a   Massetti, Greta M ^a   Paul Doria Rose, V ^b   Saraiya, Mona ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NCI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; MORTALITY; PAPANICOLAOU TEST; RISK FACTOR; TRENDS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; UTILIZATION; YOUNG ADULT;

ADULT; AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; PAPANICOLAOU TEST; RISK FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84910056114     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Moyer VA. Screening for cervical cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880-91.
2. Howlader N, Noone AM, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2011. Bethesda, MD: National Cancer Institute; 2013. Available at http://seer. cancer. gov/csr/1975_2011.
3. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137: 516-42.
4. Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005.
5. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005; 97: 675-83.
6. Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS. Challenges in meeting healthy people 2020 objectives for cancer-related preventive services, NHIS, 2008-2010. Prev Chronic Dis 2014; 11: 130174.
7. CDC. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 2012; 61: 410-3.
8. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation of age-adjusted cancer rates. Stat Methods Med Res 2006; 15: 547-69.
9. Benard VB, Watson M, Castle P, Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol 2012; 120: 1117-23.
10. Horner MJ, Alterkruse SF, Zou J, Wideroff L, Katki HA, Stinchomb DG. US geographic distribution of pre-vaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev 2011; 20: 591-9.
11. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008; 113(Suppl): 2855-64.
12. US Department of Health and Human Services Coverage of certain preventive services under the Affordable Care Act: final rules. 45 CFR Parts 147 and 156. July 19, 2010. Washington, DC: US Department of Health and Human Services; 2010.
13. Scarinci IC, Garcia FAR, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010; 116: 2531-42.
14. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Recomm Rep 2014; 63(No. RR-5).
15. Elam-Evans LD, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep 2014; 63: 625-33.
16. Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination. J Natl Cancer Inst 2008; 100: 308-20.
17. Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer. 2014; 120: 2032-8.